Postpartum Hemorrhage
Conditions
Brief summary
A group of midwives and obstetric nurses have been trained to use circumferential abdominal pelvic pressure (CAPP) to treat postpartum hemorrhage. As part of the training follow up any use of a CAPP device will be monitored to identify complications.
Detailed description
Providers will be surveyed twice at 4 and 8 months using open ended methods.
Interventions
DEVICECAPP use
Any abdominal pelvic pressure
Sponsors
University of New Mexico
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
No
Inclusion criteria
* Any patient receiving CAPP during study period.
Exclusion criteria
* None (CAPP is only clinically indicated for obstetric hemorrhage post delivery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Usage | Eight months | Number of patients on whom CAPP is used |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Side Effects | Eight months | Any recorded complications |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| CAPP Application Patients in whom device is used | 10 |
| Total | 10 |
Baseline characteristics
| Characteristic | CAPP Application |
|---|---|
| Age, Categorical <=18 years | NA Participants |
| Age, Categorical >=65 years | NA Participants |
| Age, Categorical Between 18 and 65 years | NA Participants |
| Age, Continuous | NA years |
| Sex: Female, Male Female | 10 Participants |
| Sex: Female, Male Male | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | — / — |
| other Total, other adverse events | 0 / 10 |
| serious Total, serious adverse events | 0 / 10 |
Outcome results
Primary
Usage
Number of patients on whom CAPP is used
Time frame: Eight months
Population: Entire number of participants
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| CAPP Application | Usage | 10 participants |
Secondary
Side Effects
Any recorded complications
Time frame: Eight months
Population: All patients
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| CAPP Application | Side Effects | 0 participants |